Intranasal plasma rich in growth factors (PRGF)-Endoret provides a novel neuroprotective strategy for DA and attenuates NF-κB-dependent inflammation processes in a PD model (Anitua et al., 2015). Here, NFKB1 is linked to Parkinson disease.